Pancreatic Diseases
Conditions
Brief summary
Endoscopic retrograde cholangiopancreatography (ERCP (, a key tool that is used in diagnosis and treatment of pancreato-biliary diseases. Post-ERCP pancreatitis (PEP) is the most common and serious complication that can occur following this procedure and can lead to significant morbidity and mortality. A variety of patient-related and procedure-related factors have been associated with higher rates of PEP.
Interventions
OTHERPlacebo
Placebo tablets will have the same look and appearance of ondansetron.
DRUGOndansetron
ondansetron is commonly used as anti-emetics to prevent and treat chemotherapy-induced vomiting and nausea
Sponsors
Tanta University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Masking description
double blinded
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
1. Age more than 18 years old. 2. Gender: Males and Females 3. Patients with suitable indications for ERCP due to suspected pancreato-biliary disorders. 4. Blood amylase and lipase levels before ERCP are within the normal limits.
Exclusion criteria
1. Age of less than18 years. 2. Uncontrolled diabetes mellitus (DM) 3. Severe bleeding tendency 4. Impaired renal function (serum creatinine \> 2 mg/dL), (creatinine clearance \<30 ml/min) 5. Patients with severe heart disease. 6. Subjects who underwent prior biliary or pancreatic sphincterotomy or dilatation or stenting of either duct. 7. Currently pregnant or nursing 8. Admission due to established pancreatitis before ECRP 9. Unwillingness to undergo ERCP. 10. Previously documented allergy to ondansetron.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The primary outcome that will be measured is the development of pancreatitis after the procedure according to consensus criteria | 24 hours | The primary outcome that will be measured is the development of pancreatitis after the procedure according to consensus criteria. Briefly in this criteria PEP will be diagnosed if the Patient met two of the three following criteria after ERCP: new onset or increased abdominal pain consistent with acute pancreatitis, pancreatic enzyme elevation to at least 3 times the upper limit of normal at 24 hours after the procedure, and the necessity for new or continued hospitalization for at least 2 nights |
Countries
Egypt
Outcome results
None listed